The major aim of the present study is to develop and explore the potential of large surface area electrospun polymer nanofabric as a carrier for controlled and sustained release, in particular for hydrophobic drugs. Gelatin (type A), FDA approved natural polymer was electrospun in a mixture of solvent (20% acetic acid in water) to yield long, continuous and uniform fibers with average diameter ~ 200 nm. Piperine was chosen as a model hydrophobic drug in this study. As gelatin is highly soluble in aqueous medium, we crosslinked electrospun gelatin nanofibers using saturated GTA vapor to increase the water resistive properties. For controlled release over a period of 12 h, we devised several strategies to vary the crosslinking conditions and accordingly understand their effect on drug release mechanism. One of such successful efforts was based on deposition of multiple layers of electrospun fabric by sandwiching between drug loaded gelatin nanofibers and without drug gelatin nanofibers from both sides. Not only the layer by layer deposition, we also crosslinked the different layer in the same sequential way. Sequential crosslinking using GTA vapor in different layers of the fabric, helped in uniform crosslinking throughout the thickness compared to crosslinking after final deposition in the form of a single layer. Effect of different crosslinking strategies was investigated in terms of surface morphology and drug stability. Finally, in-vitro release study was performed maintaining the physiological conditions mimicking GI tract to analyze the effect of crosslinking on the drug release profile. The in-vitro studies concluded that the controlled drug release can be achieved by tuning the thickness of individual fabric layer followed by their sequential crosslinking, which finally affects the diffusional barrier for drug release. Interestingly, we also found that only 6 min exposure to saturated GTA vapor is sufficient to provide the required drug release in contrast to up to 24 h as reported in literature. This finding also addresses the toxicity problem associated with the use of GTA as a cross-linker.
INTRODUCTION
The main challenge of any drug delivery system (DDS) is to deliver pharmaceutical agent or drug in a predetermined manner for a defined time interval according to the treatment requirements [1] . Polymer based DDS has received considerable attention because of its therapeutic efficacy and lower side effect. Researcher has fused polymer science and technologies in order to develop different DDS for biomedical and pharmaceutical applications [2] [3] [4] [5] [6] . One such development is in the area of using polymeric nanofiber as DDS due to their large surface area and porosity [7] [8] .
Electrospinning is a straightforward and cost effective way to form natural and synthetic polymeric fibers in the size range of nano to few microns [8] . The use of natural polymers in biomedical area has drawn attention from few decades and approved by FDA, because of its biocompatible and non-toxic effect on biological system [9] . Further modifications in functionality and crosslinking of natural polymers have been made to overcome the drawback of poor structural and mechanical stability in aqueous medium [10, 11] .
Gelatin is a FDA approved natural polymer, which has been used extensively in pharmaceutical industries as excipients for pharmaceutical agents [9] . Gelatin is partially hydrolyzed from collagen which is mainly found in bones, connecting tissues, cartilage of animal. Due to poor structural consistency in aqueous conditions, gelatin nanofibers are crosslinked using glutaraldehyde (GTA) vapor for biomedical applications [10, 11] . In our recent study [12] , we have successfully crosslinked gelatin nanofibers with saturated GTA vapors within a range of 6 to 8 min to sustain the mesh in aqueous medium for more than 24 h. This can reduce the potential toxicity by cutting down the exposure time in GTA vapor from hours to minutes [10, 12] . Additionally, hydrophobic piperine molecules in the matrix as drug played a major role in repelling the water molecules and acted as a safeguard of the nano-fiber mat. Thus, by reducing the exposure time for crosslinking one can reduce the toxicity as well as can protect the fiber structure from degradation [12] .
Here in this study, we are comparing the release profile of hydrophobic drug, piperine, using three strategies: using gelatin nanofiber mesh with 6 min of crosslinking with GTA vapor (GNF-P C6), using gelatin nanofiber mesh with sequential crosslinking with GTA vapor (GNF-P SC6) and using sandwiched gelatin nanofiber mesh with sequential crosslinking with GTA vapor (SGNF-P S-C6). The main drawback of direct crosslinking for 6 min (GNF-P C6) is excessive shrinkage of the nanofiber mesh. To overcome that problem associated with non-uniformity of crosslinking in different layers, we suggest sequential crosslinking (SGNF-P-S-C6). To increase the diffusional barrier and to overcome the initial fast release of drug we further fabricated sandwiched gelatin nanofiber mesh with same manner of sequential crosslinking with GTA vapor (SGNF-P S-C6). Here, a comparative study among these is made in terms of morphology, chemical and thermal stability of the mesh. The need of the study is to investigate the crosslinking effect on the degradation of multi-layered nanofiber mesh with minimized GTA vapor exposure, so that, the toxic effect of GTA can also be avoided as much as possible. Finally, we have also investigated the potential application of the mesh as a drug delivery system using piperine as a hydrophobic model drug.
EXPERIMENTAL SECTION Materials
Gelatin (Type A, 175 bloom), Piperine (98%), Gluteraldehyde (25% v/v aqueous solution), Acetic acid (glacial, ACS, 99.7+%), Hydrochloric acid (ACS, 36.5-38.0%), Sodium hydroxide pallets (98%), Phosphate buffer saline (pH 7.4) were purchased from Alfa Aesar (A Johnson Matthey Company, India). Deionized water (DI) (Milli Q water 18.1 Ω) was used throughout the experiments. All the chemicals were used without further purification.
Fabrication of nanofiber mesh
Electrospinning solution was made by preparing homogeneous solution of gelatin (type A) in acetic acid solution (20% v/v in distilled water) under constant magnetic agitation and at a constant room temperature for 3 h. Piperine, as a model drug was added in the concentration of 2 mg/ml in the homogeneous gelatin solution to prepare drug loaded nanofiber mesh. All the solutions were prepared Nanofiber mesh were fabricated using electrospinning apparatus (E Spin Nanotech Pvt. Ltd, India). To fabricate nanofiber mesh, 5 ml of solution was deposited on aluminum foil using electrospinning process. The voltage and distance between needle tip (21 gauge) and collector was 12 kV and 10 cm respectively. The solution flow rate was 5μl/min.
To crosslink the nanofiber mesh, gelatin nanofiber deposited aluminum foil were cut into 2 × 2 cm 2 and placed inside the closed glass desiccator with 20 ml of GTA solution (25% v/v aqueous solution) for few minutes. Different crosslinking strategies as well as deposition pattern was done shown in Figure 1 . Firstly, GNF-P C6 was prepared by crosslinking GNF-P mesh for once with 6 min of exposer in GTA vapor after complete deposition of 5 ml solution. For GNF-P SC6, the sample was crosslinked in sequential manner i.e. after spinning 1ml of solution of GNF-P; it was crosslinked for 2 min followed by further deposition of fibers of 3 ml solution with subsequently crosslinking and so on. For SGNF-P SC6, the sample was crosslinked in same sequence (2+2+2) min maintaining total crosslinking time same (6 min). In addition to that, piperine loaded gelatin layer was sandwiched by only gelatin nanofiber layers in both side. 
Characterization
The morphology of the nanofiber meshes were taken by table top scanning electron microscopy (SEM) (Phenom world, Model: Pro X). Prior to imaging, the sample was placed on a stub and the sample was coated with thin gold layer using sputter coater (Excel Instruments, India).
To understand the effect of different crosslinking mechanism on stability of the mesh invitro degradation was carried out for GNF-P C6, GNF-P SC6 and SGNF-P SC6 in pH 7.4. All the cases samples were cut in equal size and weighed (W i ) and were placed in 10 ml of PBS (pH 7.4) solution at 37 0 C for 50 h. At the fixed time intervals, swelled samples were taken out and dried in a vacuum oven at room temperature and weighed (W f ) again. The weight loss (WL%) is calculated by using the following equations [13] To check the functional group of polymer and drug, Fourier Transform Infra-Red spectroscopy (FTIR) (Bruker Corp., Tensor 37) were performed in transmittance mode in 400-4000 cm -1 range with a resolution of 4 cm −1 and 256 scans per samples at room temperature. To study the effect of different crosslinking strategies on controlling release of piperine from gelatin nanofiber matrix, in-vitro release study was performed maintaining the physiological conditions. GNF-P C6, GNF-P SC6 and SGNF-P SC6 were cut into equal size of pieces and placed in 30 ml of release medium with different pH levels (1.2 similar to pH of stomach and 7.4 similar to pH of intestine) maintaining the temperature and shaking speed of the mechanical shaker (Remi RIS-24 plus) 37 0 C and 150 RPM respectively. Adequate amount of samples were taken from the release medium at a fixed time intervals and fresh solution was added back to maintain the sink condition. The presence of piperine in release medium was detected using UV spectrophotometer (Perkin Elmer, Lambda 35) at 342 nm as λ max for piperine. All results were performed thrice to confirm reproducibility of the results.
RESULTS & DISCUSSION
Gelatin consists of amino acids and lysine is one of them, which reacts with GTA within a very short span of time. Though, GTA is widely used to crosslink any collagen, toxicity associated with GTA vapor is a matter of concern in case of biomedical applications. Thus, reducing the exposer time in GTA vapor to avoid cytotoxicity is an important step while using nanofiber as drug delivery system. Recently, we found that 6 to 8 min of crosslinking with GTA vapor was enough to sustain in aqueous medium for more than 24 h [12] . Further we realized the fact that while crosslinking with GTA vapor, the crosslinking was not uniform in every layer of the fabric. Eventually the layer by layer sequential crosslinking came in the scenario. This hierarchy in crosslinking throughout the layers caused excessive shrinkage in the mesh. This non-uniformity of the crosslinking leads to less water resistivity as compared to sequential crosslinking. In case of sequential crosslink, the carbonyl group (C=O) of aldehyde can react with amino acid of gelatin in a uniform manner thus causing better compactness of the fabric than one time final crosslinking for 6 min. This uniformity of crosslinking throughout the layers in between plays an important role in terms of the stability of the mesh and also mobility of drug molecules. As a next step, we have also tried to change the deposition pattern of drug loaded nanofiber mesh. Piperine loaded gelatin nanofiber layer was sandwiched by only gelatin nanofiber mesh. The crosslinking of the mesh was done in sequential manner as discussed earlier (Figure 1 ). The present effort has tried to achieve sequential crosslinking with minimal exposure of GTA unlike the crosslinking up to few days as reported in literature [10] .Thus, we can avoid the toxicity associated with GTA. At the same time, our aim was to achieve a good control on the initial fast release in for a sustained drug release profile.
The morphology of GNF-P C6, GNF-P SC6 and SGNF-P SC6 are presented in Figure 2 . As gelatin nanofiber is very sensitive to moisture, the water molecules present in 25% v/v of GTA saturated vapor damages the outer layer of the mesh by fusing fibers together. The more the exposer time, more is the state of fused fiber structure. Thus GNF-P C6 (Figure 2a) showed much more damaged structure in comparison to GNF-P SC6 and SGNF-P SC6. In both GNF-P SC6 and SGNF-P SC6 samples the exposure time for the top layer is limited to only 2 min results intact fiber structure (Figure 2b and 2c respectively).
Figure 2:
SEM images of GNF-P C6, GNF-P SC6 and SGNF-P SC6. Figure 3a showed that the weight loss (WL) (%) due to hydrolytic degradation in the case of GNF-P C6, GNF-P SC6 and SGNF-P SC6 were 15.2 ± 1.5%, 12.4 ± 1.2% and 12.1 ± 1.6% respectively in pH 7.4 after 50 h. The WL (%) showed less in GNF-P SC6 and SGNF-P SC6 in compare to GNF-P C6 which clearly indicated the stability of the nanofiber mesh in aqueous medium [12] . This WL (%) was mainly due to the degradation of polymer followed by the release of piperine. Thus this part was directly involved with release study of piperine.
The FT-IR spectra of GNF-P C6, GNF-P SC6 and SGNF-P SC6 were done to understand the underlying mechanism of crosslinking and drug-polymer interactions and presented in Figure  3b . All the gelatin based nanofiber shows distinct characteristic bonds of amide I (C O and C N stretch), II (N H bend and C H stretch) and III around 1630 cm -1 , 1540 cm -1 and 1240 cm -1 [12] . The peak for asymmetric stretching of =C-O-C around 1220 cm -1 indicates the presence of piperine in polymer matrix. The shift of peaks towards low wavelength after 6 min of crosslinking is also a good indicator crosslinking [12, 14] . As a next step, in-vitro drug release study was done to investigate the role of different crosslinking strategies on release study of piperine. Figure 3c illustrates the cumulative release (%) of piperine as a function of time (h) for 24 h in different pH. The release (%) of piperine from GNF-P C6, GNF-P SC6 and SGNF-P SC6 meshes in pH 7.4 for 24 h are 65.4 ± 4.5%, 55.2 ± 3.5 % and 48.8 ± 4.6% respectively. GNF-P C6 shows initial fast release in compare to GNF-P SC6 mesh. Result shows that sequential crosslinking not only can take control on the initial fast release of piperine upto 8 h, but also can reduce the overall release. Release of GNF-P C6 (57.7 ± 2.5%) sustainably reduced in the case of GNF-P SC6 (40.1 ± 1.2) by designing the vehicle with sequential crosslinking method. Further, we have sandwiched piperne loaded gelatin nanofiber mesh and without drug gelatin nanofiber mesh in the both sides in order to investigate the effect of barrier on release profiles. Similar sequential crosslinking has done for sandwiched gelatin nanofiber mesh. The idea is to increase the diffusional barrier between the drug molecules and release medium. Similarly, after 8h of study, almost 20% of drug release was tailored for SGNF-P SC6 (38.1 ± 2.1%) in compare to GNF-P C6. Sandwiched structure did not show much significant control over release than sequential crosslinking. Similar observation we can see in case of pH 1.2. Typically, the vehicle will stay in the stomach (pH 1.2) for 4-5 h and will reach to the absorption site i.e. small intestine (pH 7.4). Thus good control on the release in pH 1.2 also observed with uniform crosslinking of the fiber within in between layers of the mesh.
To understand the release mechanism, release data was fitted in the classical Higuchi model and respective Higuchi dissolution constants are presented in Table 1 . The decrease of K H value represents the increase in diffusional barrier which is due to the uniformity of crosslinking of samples. Thus the compactness of the mesh is maintained and the mobility of drug molecules is restricted which ultimately is reflected in the improved sustained release profile. 
CONCLUSIONS
As demonstrated in results, the different strategies of crosslinking certainly play important roles to controlling drug release from gelatin nanofiber based system. Results from our previous study demonstrated excellent stability of the mesh in aqueous medium for more than 48 h with only 6 to 8 min of crosslinking. In this study, we are focused on further development of the system by addressing the problem of non-uniform crosslinking of in between layers in case of one time final crosslinking. Thus, sequential layer by layer crosslinking (2+2+2 min) of gelatin nanofiber mesh was done by keeping the total crosslinking time constant (6 min). As expected, uniformity of crosslinking in different layers was achieved. As a result, strong interfibrous bonding was form because of evenly crosslinking, which in turn controlled the mobility of drug molecules. Further, sandwiched gelatin nanofiber mesh was fabricated to increase the diffusional barrier between drug molecules and release medium. Results suggest this nanofiber based delivery system can be used as a potential drug delivery system with sustained release of drug molecules for a prolong period of time.
